News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synexus Further Expands Its Global Footprint With An Acquisition In South Africa


8/27/2014 11:15:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MANCHESTER, England--(BUSINESS WIRE)--Synexus has expanded its global presence with the acquisition of a specialist clinical trial site close to Cape Town’s international airport. This is its fourth dedicated research centre in South Africa and brings Synexus global site count to 24 with 3 new centres being opened in the last six months.

Synexus’ continued global success is driving its international expansion. Its order book is at a record high and continuing to grow. The increased number of sites will ensure Synexus is able to continue to meet increasing demands from CROs and pharma.

The new Synexus site in South Africa is the Helderberg Clinical Trials Centre which has been in existence since 1994. It will now be known as the Synexus Helderberg Clinical Research Centre. Dr Graham Ellis, who founded the Centre, has been appointed Medical Director and will continue as the Centre Manager. Dr Ellis will continue to lead an unchanged investigator and clinical team.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Synexus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES